 | Up a level |
Hagel, Stefan 
ORCID: 0000-0003-2999-6131, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, Koenig, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Mueller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A., Pletz, Mathias W. and Investigators, The Target Trial
(2022).
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
Intensive Care Med., 48 (3).
S. 311 - 322.
NEW YORK:
SPRINGER.
ISSN 1432-1238
Hagel, Stefan ORCID: 0000-0003-2999-6131, Bach, Friedhelm, Brenner, Thorsten, Bracht, Hendrik, Brinkmann, Alexander, Annecke, Thorsten, Hohn, Andreas, Weigand, Markus Alexander, Michels, Guido, Kluge, Stefan, Nierhaus, Axel, Jarczak, Dominik, Koenig, Christina, Weismann, Dirk, Frey, Otto, Witzke, Dominic, Mueller, Carsten, Bauer, Michael, Kiehntopf, Michael, Neugebauer, Sophie, Lehmann, Thomas, Roberts, Jason A. and Pletz, Mathias W.
(2022).
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial (vol 48, pg 311, 2022).
Intensive Care Med., 48 (5).
S. 646 - 648.
NEW YORK:
SPRINGER.
ISSN 1432-1238